Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Haleon Plc covers the month of June 2026, specifically reporting on share buyback activities concluded on June 22, 2026. Haleon is a consumer health company focused on everyday health, with a portfolio spanning oral health, vitamins, pain relief, respiratory health, digestive health, and therapeutic skin health.
Key Financial Metrics and Capital Actions
The filing details a share repurchase program rather than operational financial results. Key metrics include:
- Total Shares Purchased: 14,288,204 ordinary shares for cancellation.
- Share Price Range: Purchases occurred between June 16 and June 18, 2026, with prices ranging from a low of 328.5000 pence to a high of 335.0000 pence.
- Volume Weighted Average Price (VWAP): Varied by exchange and date, generally between 330.7439 pence and 334.4574 pence.
- Post-Transaction Capital Structure: Registered share capital stands at 8,827,898,857 ordinary shares. Treasury shares held are 12,022,709.
- Voting Rights: The number of ordinary shares with voting rights is 8,815,876,148.
The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity for the period.
Material Changes
The primary material change is the reduction of the company's share count due to the cancellation of 14,288,204 shares under the buyback program announced on March 12, 2026. No other material changes to operations or financial position are disclosed in this specific filing.
Guidance, Outlook, and Risks
This filing contains no management commentary, financial guidance, or outlook for future periods. It includes a standard disclaimer that the announcement does not constitute an offer or solicitation of an offer for securities. The filing references the Market Abuse Regulation (EU) No 596/2014 regarding the disclosure of individual trades.
Investor Verification Checklist
- Verify the total cost of the buyback by calculating the weighted average price against the 14,288,204 shares purchased.
- Confirm the updated share count of 8,815,876,148 voting shares for compliance with disclosure thresholds.
- Review the full trade breakdown available via the provided London Stock Exchange link for granular execution details.
- Check subsequent filings for the impact of this buyback on earnings per share (EPS) and return on equity (ROE).